Menstrual Recovery and Reproductive Outcomes After Fertility‐Sparing Surgery and Adjuvant Chemotherapy for Malignant Ovarian Germ Cell Tumors: A Retrospective Cohort Study
Journal of Obstetrics and Gynaecology Research · 2026
DOI: 10.1111/jog.70462 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Obstetrics and Gynaecology Research, 2026. Verfasst von Aroontorn Pichatechaiyoot und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand. Hauptthemen laut MEDLINE: Neoplasms, Germ Cell and Embryonal, Ovarian Neoplasms, Fertility Preservation, Menstruation. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Aim
To evaluate menstrual recovery, reproductive outcomes, and survival following fertility‐sparing surgery and platinum‐based chemotherapy in women with malignant ovarian germ cell tumors (MOGCTs).
Methods
We retrospectively reviewed women aged 15–40 years with MOGCT treated at a university hospital (2001–2012). All underwent fertility‐sparing surgery and platinum‐based chemotherapy. Menstrual and reproductive outcomes were assessed through structured interviews and compared with age‐matched controls. Survival outcomes were analyzed by Kaplan–Meier method.
Results
Among 1934 ovarian cancer cases, 209 (10.8%) were MOGCT; 44 patients met inclusion criteria and were matched to 44 controls. Median age was 21 years; dysgerminoma was the most common histology (40.9%), and 70.4% had Stage I disease. All received bleomycin, etoposide, and cisplatin (median 4 cycles). After a median follow‐up of 55 months, 97.7% resumed menstruation. Compared with baseline and controls, cycles were shorter (4 vs. 5 days, p = 0.026), lighter (2 vs. 3 pads/day, p = 0.004–0.047), and longer in interval (29.2 vs. 26.4 days, p < 0.001). Of 17 patients attempting conception, 9 achieved 10 pregnancies, with a pregnancy rate of 52.9% and live‐birth rate of 90.9%, without congenital anomalies. Only one recurrence occurred, with 10‐year progression‐free and overall survival of 95.3% and 97.9%, respectively.
Conclusions
Fertility‐sparing surgery followed by platinum‐based chemotherapy was associated with excellent long‐term survival, high rates of menstrual recovery, and favorable reproductive outcomes in young women with MOGCT. These findings support current international recommendations for fertility‐preserving treatment in selected patients and provide long‐term evidence from a Southeast Asian cohort.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand.
- Bangkok Rayong Center Hospital, Rayong, Thailand.
- Department of Pathology, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand.
ORCID-Profile: Aroontorn Pichatechaiyoot, Rakchai Buhachat, Wanapa Naphatthalung, Nungrutai Saeaib, Kanet Kanjanapradit
Zitieren
APA
Pichatechaiyoot, A., Buhachat, R., Naphatthalung, W., Saeaib, N., & Kanjanapradit, K. (2026). Menstrual Recovery and Reproductive Outcomes After Fertility‐Sparing Surgery and Adjuvant Chemotherapy for Malignant Ovarian Germ Cell Tumors: A Retrospective Cohort Study. Journal of Obstetrics and Gynaecology Research. https://doi.org/10.1111/jog.70462
Vancouver
Pichatechaiyoot A, Buhachat R, Naphatthalung W, Saeaib N, Kanjanapradit K. Menstrual Recovery and Reproductive Outcomes After Fertility‐Sparing Surgery and Adjuvant Chemotherapy for Malignant Ovarian Germ Cell Tumors: A Retrospective Cohort Study. Journal of Obstetrics and Gynaecology Research. 2026. doi:10.1111/jog.70462
BibTeX
@article{Pichatechaiyoot2026,
author = {Pichatechaiyoot, Aroontorn and Buhachat, Rakchai and Naphatthalung, Wanapa and Saeaib, Nungrutai and Kanjanapradit, Kanet},
title = {Menstrual Recovery and Reproductive Outcomes After Fertility‐Sparing Surgery and Adjuvant Chemotherapy for Malignant Ovarian Germ Cell Tumors: A Retrospective Cohort Study},
journal = {Journal of Obstetrics and Gynaecology Research},
year = {2026},
doi = {10.1111/jog.70462}
}
EUVIMED